Clinical Trial Update: Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Utidelone plus capecitabine versus a taxane plus capecitabine in HER2-negative locally advanced or metastatic breast cancer is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms
• Or Metastatic Breast Cancer

Drugs mentioned

• Taxane plus capecitabine
• Utidelone plus capecitabine

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer | Phase 3 | Status: NOT_YET_RECRUITING